
Thermo Fisher Scientific Inc. (TMO) – Expansion of Bioproduction Business
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on August 31, 2021Thermo Fisher introduced a series of developments, to augment Bioprocessing growth. At present, the company is expanding its bioproduction purification resin capacity, which is used in the mRNA manufacturing process.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– DCF Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
CrispIdea Coverage
No of Pages : 36